Christine Mauz‐Koerholz

Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation

Eva Rettinger, André Willasch, Hermann Kreyenberg et al. · Blood · 2011 · 107 citations

Medicine, Hematology, Oncology +17

Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study

Franco Locatelli, Christine Mauz‐Koerholz, Kathleen Neville et al. · The Lancet Haematology · 2018 · 100 citations

Medicine, Oncology, Pharmacotherapy +16

Interdisciplinary care programme to improve self-management for cancer patients undergoing stem cell transplantation: a prospective non-randomised intervention study

Heike Schmidt, Stephanie Boese, Alexander Bauer et al. · European Journal of Cancer Care · 2016 · 17 citations

Medicine, Oncology, Palliative Care +16

Phase 1/2 Study Of Brentuximab Vedotin In Pediatric Patients With Relapsed Or Refractory (R/R) Hodgkin Lymphoma (HL) Or Systemic Anaplastic Large-Cell Lymphoma (sALCL): Preliminary Phase 2 Data For Brentuximab Vedotin 1.8 Mg/Kg In The HL Study Arm

Franco Locatelli, Kathleen Neville, Angelo Rosolen et al. · Blood · 2013 · 11 citations

Medicine, Oncology, Pediatrics +17

Significance of E-lesions in Hodgkin lymphoma and the creation of a new consensus definition: a report from SEARCH

Eline A. M. Zijtregtop, Jamie Zeal, Monika L. Metzger et al. · Blood Advances · 2023 · 11 citations · Full text

Medicine, Oncology, Pathology +15